Calcium scoring needed to guide statin prescribing: cardiologists
CVD prevention guidelines should be updated to include the screening tool for low- to intermediate- risk patients, says Professor Tom Marwick.
Australians at low to intermediate risk of cardiovascular disease should undergo calcium scoring to assess their eligibility for statin therapy, according to a study by leading cardiologists.
Their results suggested more widespread screening would be cost-effective if statins were initiated in patients with a baseline absolute CVD risk of at least 5% and a coronary artery calcium (CAC) score of ≥100 Agatston units (AU).
